Device type · LMF
Agent, Absorbable Hemostatic, Collagen Based
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
LMF
General & Plastic Surgery
Device class
Class III
FDA decisions since 2015
0
510(k), De Novo and PMA
Adverse event reports
105
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Agent, Absorbable Hemostatic, Collagen Based
- Product code
- LMF
- Device class
- Class III
- Review panel
- General & Plastic Surgery
- Regulation
- 21 CFR 878.4490
- Specialty
- General & Plastic Surgery, Wound Care
- FDA record
- Classification database entry for LMF
Latest FDA decisions
No 510(k), De Novo or PMA decisions for this product code since 2015.
Reports received
105
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
19
18% of reports
Injury reports
83
79% of reports
Death reports
3
2.9% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 4 | 0 | 1 |
| Jan 24 | 0 | 8 | 0 | 0 |
| Feb 24 | 1 | 14 | 0 | 0 |
| Mar 24 | 0 | 14 | 0 | 0 |
| Apr 24 | 2 | 9 | 0 | 0 |
| May 24 | 0 | 6 | 0 | 0 |
| Jun 24 | 1 | 19 | 4 | 0 |
| Jul 24 | 0 | 5 | 2 | 0 |
| Aug 24 | 2 | 19 | 1 | 0 |
| Sep 24 | 0 | 4 | 0 | 0 |
| Oct 24 | 1 | 10 | 0 | 0 |
| Nov 24 | 0 | 4 | 0 | 0 |
| Dec 24 | 1 | 7 | 0 | 0 |
| Jan 25 | 1 | 5 | 0 | 0 |
| Feb 25 | 0 | 4 | 0 | 0 |
| Mar 25 | 0 | 5 | 0 | 0 |
| Apr 25 | 0 | 6 | 0 | 0 |
| May 25 | 0 | 22 | 1 | 0 |
| Jun 25 | 0 | 7 | 0 | 0 |
| Jul 25 | 0 | 8 | 0 | 0 |
| Aug 25 | 0 | 9 | 0 | 0 |
| Sep 25 | 1 | 3 | 0 | 0 |
| Oct 25 | 0 | 3 | 0 | 0 |
| Nov 25 | 1 | 12 | 1 | 0 |
| Dec 25 | 1 | 4 | 0 | 0 |
| Jan 26 | 1 | 0 | 0 | 0 |
| Feb 26 | 1 | 11 | 0 | 0 |
| Mar 26 | 1 | 2 | 0 | 0 |
| Apr 26 | 4 | 6 | 0 | 0 |
| May 26 | 2 | 17 | 0 | 0 |
| Jun 26 | 2 | 7 | 0 | 0 |
| Jul 26 | 1 | 5 | 0 | 0 |
| Aug 26 | 1 | 5 | 0 | 0 |
| Sep 26 | 4 | 4 | 1 | 0 |
| Oct 26 | 0 | 10 | 1 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
- Pfizer23
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Adverse Event Without Identified Device or Use Problem36
- Off-Label Use27
- Patient Device Interaction Problem21
- Device Handling Problem7
- Lack of Effect7
- No Apparent Adverse Event4
- Device Contamination with Chemical or Other Material3
- Failure to Advance3
- Fluid/Blood Leak3
- Patient-Device Incompatibility3
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions29
- Post Operative Wound Infection18
- Hemorrhage/Blood Loss/Bleeding10
- Impaired Healing7
- Swelling/ Edema7
- Hypersensitivity/Allergic reaction6
- Fluid Discharge5
- Hematoma5
- Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available4
- Granuloma4
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Avitene Ultrafoam Microfibrillar Collagen Hemostat - 8cm x 6.25cm x 1cm. Catalog Number: 1050030.Open, Classified
Z-1896-2026 · Started Mar 25, 2026 · Posted by FDA Apr 21, 2026
Reason given: Potential for product to contain foreign matter, confirmed to be inspect fragments.
Cause as FDA categorized it: Under Investigation by firm
- SURGIFOAM" Absorbable Gelatin Powder Kit, Product Code 1979.Open, Classified
Z-1881-2024 · Started Apr 23, 2024 · Posted by FDA May 22, 2024
Reason given: Some applicator tips from these lots had open seals.
Cause as FDA categorized it: Under Investigation by firm
- Baxter Floseal Hemostatic Matrix Fast Prep, Product Codes: a) ADS201844, 5 mL b) ADS201845, 10mLOpen, Classified
Z-0661-2024 · Started Dec 6, 2023 · Posted by FDA Jan 5, 2024
Reason given: Cardiovascular Surgery marketing brochure (US-AS46-220001) that was distributed for the products listed below contains inaccurate content that does not align with some of the products Instructions for Use (IFU) or Prescribing Information (PI).
Cause as FDA categorized it: Under Investigation by firm
- Baxter FloSeal Hemostatic Matrix RECOTHROM, Product Codes: a) ADS202105, 5mL-6 PK US b) ADS202110, 10mL USOpen, Classified
Z-0662-2024 · Started Dec 6, 2023 · Posted by FDA Jan 5, 2024
Reason given: Cardiovascular Surgery marketing brochure (US-AS46-220001) that was distributed for the products listed below contains inaccurate content that does not align with some of the products Instructions for Use (IFU) or Prescribing Information (PI).
Cause as FDA categorized it: Under Investigation by firm
Mckesson Medical-Surgical Inc. Corporate Office
Z-1584-2022 · Started May 25, 2022 · Posted by FDA Aug 26, 2022
Reason given: Facility Temperature excursions (from June 2021-August 2021) prior to delivery; exposure to higher temperatures may have impacted product effectiveness. All lots received between 06/01/21-9/30/21.
Cause as FDA categorized it: Environmental control
Integra LifeSciences Corporation
Z-1288-2013 · Started Mar 28, 2013 · Posted by FDA May 10, 2013
Reason given: Due to the process deviation, product lots in question may have been released with higher levels of pyrogens than permitted by the specifications for the products.
Cause as FDA categorized it: Process control
Integra LifeSciences Corporation
Z-1289-2013 · Started Mar 28, 2013 · Posted by FDA May 10, 2013
Reason given: Due to the process deviation, product lots in question may have been released with higher levels of pyrogens than permitted by the specifications for the products.
Cause as FDA categorized it: Process control
Integra LifeSciences Corporation
Z-1290-2013 · Started Mar 28, 2013 · Posted by FDA May 10, 2013
Reason given: Due to the process deviation, product lots in question may have been released with higher levels of pyrogens than permitted by the specifications for the products.
Cause as FDA categorized it: Process control
Showing the 8 newest of 27 recall records in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.